Skip to content
Triangle logo TriangleGet started
← All settings

DISEASE & TREATMENT SETTING

Monoclonal Gammopathy of Undetermined Significance

Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.

Exact scope

Monoclonal Gammopathy of Undetermined Significance

Source population
Not part of this definition
Disease extent
Not part of this definition
Treatment line
Not part of this definition
Stage
Not part of this definition
Resectability
Not part of this definition
Biomarkers, prior therapy and derivation
molecular
    prior therapy
      derivation status
      source-attested
      derivation note
      Added because the terminology and the registry both attest it: an NCIt neoplasm concept named by 2 acquired study condition(s). It is absent from the NCI treatment-topic directory, which is not an exhaustive cancer inventory.
      source wording
      Source null

      Study evidence for this setting

      7 linked studies · Applicability is a draft source assessment, not a determination of your eligibility.

      NCT00099047 · Registry condition search · Scope: narrower

      Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma

      1 outcome links · 2 safety-group records · 0 quality-of-life measures

      →

      NCT00899353 · Registry condition search · Scope: narrower

      Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM)

      2 outcome links · 1 safety-group records · 1 quality-of-life measures

      →

      NCT01237054 · Registry condition search · Scope: narrower

      Imaging in MGUS, SMM and MM

      6 outcome links · 1 safety-group records · 1 quality-of-life measures

      →

      NCT03951220 · Registry condition search · Scope: narrower

      The Development and Pilot Testing of a New MR Imaging Protocol to Quantify Myeloma Disease Burden and Bone Loss

      6 outcome links · 3 safety-group records · 5 quality-of-life measures

      →

      NCT04731844 · Registry condition search · Scope: narrower

      Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer

      3 outcome links · 3 safety-group records · 0 quality-of-life measures

      →

      NCT04850846 · Registry condition search · Scope: narrower

      Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma

      6 outcome links · 2 safety-group records · 1 quality-of-life measures

      →

      NCT04920084 · Registry condition search · Scope: narrower

      A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

      2 outcome links · 1 safety-group records · 0 quality-of-life measures

      →
      Source relationships and population-mapping limitations
      bindings
      1. release id
        clinical-indications-draft-1
        disease state id
        ds-monoclonal-gammopathy-of-undetermined-significance
        binding id
        ncit-C3996
        source collection
        ncit-concept
        source key
        C3996
        source excerpt
        Source null
        match status
        exact
        match note
        Source null
        recorded at
        2026-09-10T00:00:00Z
      mappings

        Download this complete draft source relationship record →

        Preserved source evidence · Not medical advice